Invalid Symbol

Stock Research for CBRX

CBRX
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

CBRX Stock Chart & Research Data

The CBRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CBRX Due diligence Resources & Stock Charts

The CBRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CBRX Detailed Price Forecast - CNN Money CNN View CBRX Detailed Summary - Google Finance
Yahoo View CBRX Detailed Summary - Yahoo! Finance Zacks View CBRX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CBRX Trends & Analysis - Trade-Ideas Barrons View CBRX Major Holders - Barrons
NASDAQ View CBRX Call Transcripts - NASDAQ Seeking View CBRX Breaking News & Analysis - Seeking Alpha
Spotlight View CBRX Annual Report - CompanySpotlight.com OTC Report View CBRX OTC Short Report - OTCShortReport.com
TradeKing View CBRX Fundamentals - TradeKing Charts View CBRX SEC Filings - Bar Chart
WSJ View Historical Prices for CBRX - The WSJ Morningstar View Performance/Total Return for CBRX - Morningstar
MarketWatch View the Analyst Estimates for CBRX - MarketWatch CNBC View the Earnings History for CBRX - CNBC
StockMarketWatch View the CBRX Earnings - StockMarketWatch MacroAxis View CBRX Buy or Sell Recommendations - MacroAxis
Bullish View the CBRX Bullish Patterns - American Bulls Short Pains View CBRX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CBRX Stock Mentions - StockTwits PennyStocks View CBRX Stock Mentions - PennyStockTweets
Twitter View CBRX Stock Mentions - Twitter Invest Hub View CBRX Investment Forum News - Investor Hub
Yahoo View CBRX Stock Mentions - Yahoo! Message Board Seeking Alpha View CBRX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for CBRX - SECform4.com Insider Cow View Insider Transactions for CBRX - Insider Cow
CNBC View CBRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CBRX - OTC Markets
Yahoo View Insider Transactions for CBRX - Yahoo! Finance NASDAQ View Institutional Holdings for CBRX - NASDAQ


Stock Charts

FinViz View CBRX Stock Insight & Charts - FinViz.com StockCharts View CBRX Investment Charts - StockCharts.com
BarChart View CBRX Stock Overview & Charts - BarChart Trading View View CBRX User Generated Charts - Trading View


Latest Financial News for CBRX


Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969


Juniper Pharmaceuticals Announces Appointment of Jeffrey Young as Chief ...
PR Newswire (press release) - Dec 20, 2016
BOSTON, Dec. 20, 2016 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced the appointment of Jeffrey Young as Chief Financial Officer, Treasurer and Secretary ...

Juniper Pharmaceuticals: A High Risk, High Reward Women's Health Play
Seeking Alpha - Oct 27, 2017
Juniper is a fast-growing female health company with a clean balance sheet and expanding margins. Its shares currently trade at a wide discount to peers, and while some of this discount is warranted, I expect the gap to close significantly.

Juniper Pharmaceuticals Announces Results of 2017 Annual Meeting
PR Newswire (press release) - Jul 5, 2017
The Company is advancing a pipeline of proprietary product candidates that leverage its differentiated intravaginal ring technology and when appropriate the 505(b)(2) regulatory pathway.

Juniper Pharmaceuticals' (JNP) CEO Alicia Secor on Q3 2017 Results - Earnings ...
Seeking Alpha - Nov 5, 2017
I'm thrilled to report that we delivered a strong performance in the third quarter, marked by revenue growth of 19% for CRINONE and 38% for Juniper Pharma Services, or JPS, year-over-year. Additionally, we ended the quarter cash positive with just over ...

Enter a stock symbol to view the stock details.